Psyence Biomedical Ltd. Recorded Big Gain
Tue, Mar 05, 2024 at 07:20 PM
Psyence Biomedical Ltd. (PBM:NASDAQ) rocketted at $0.86, a gain of 40.7%. On Tue, Mar 05, 2024, PBM:NASDAQ touched a New 2-Week High of $0.86. From Wed, Feb 21, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Tue, Mar 05, 2024 at $1.1 with a volume of 6M+.
About Psyence Biomedical Ltd. (PBM:NASDAQ)
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.
Top 10 Gainers:
- Airship AI Holdings Inc Com (AISP:NASDAQ), 200%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- BeyondSpring Inc. (BYSI:NASDAQ), 76.83%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 64.38%
- CareMax Inc. (CMAX:NASDAQ), 54.22%
- JanOne Inc. (JAN:NASDAQ), 53.37%
- Phoenix New Media Limited (FENG:NYSE), 46.18%
- Enviva Partners, LP (EVA:NYSE), 42.48%
- Apogee Therapeutics Inc. (APGE:NASDAQ), 42.07%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 40.71%